Effects of a nutritional intervention in overweight/obese breast cancer patients
Tóm tắt
Today breast cancer (BC) patients can expect more prolonged survival than in the past, but obesity at diagnosis and/or weight gain during adjuvant therapies increase the risk of recurrences as well as of weight-related disorders (diabetes, cardiovascular disease…). Therefore lifestyle intervention might offer a valuable approach to positively influence the prognosis of survivors. The charts of 189 overweight/obese outpatients with “early-stage BC” were reviewed to evaluate the effects of nutritional intervention on weight, body mass index (BMI), waist circumference and metabolic parameters. After the first clinical evaluation, in 97 subjects (education group), dieting therapy and periodical medical examinations were connected with brief individual sessions of nutritional education. Instead, 92 patients (no-education group) were treated only with diet and routine visits. At baseline and after nearly 1 year of treatment, data (weight, waist circumference, BMI, systolic and diastolic pressure, metabolic parameters and results of a battery of self-administered questionnaires to assess Nutritional Knowledge (NK), Physical Functioning (PF) and Quality Of Life (QOL) of patients) were collected and compared. Ninety-two (48.7%) patients completed a oneyear follow-up. The dropout rate was higher (73.2%) in traditionally treated women (no-education group) than in education group patients (22.8%); these data highlight that more educated patients completed the programme than non-educated patients (ODs 9.2, p < 0.000). The low follow-up rate makes any comparison between the 2 types of treatment impossible since the weight and metabolic changes of the vast majority of the non-educated subjects remain unknown. Anyway, the education group patients, in active follow-up at 1 year, showed significant weight loss (−6.6 kg, SD 3.7) and improvements of metabolic parameters and questionnaire scores. Data from the study show the usefulness of this simple nutritional education intervention, which appears to increase the adherence to a weight loss programme. In educated patients who completed a 1-year follow-up, the weight reduction and metabolic changes were significant, but the analysis was carried out on less than half of the subjects and this very high global dropout rate (51.3%) makes it impossible to draw generalised conclusions.
Tài liệu tham khảo
Loi S, Milne RL, Friedlander ML et al (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1686–1691
Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128–1143
Daling JR, Malone KE, Doody DR et al (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92:720–729
Berclaz G, Li S, Price KN et al (2004) Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15:875–884
Dignam JJ, Wieand K, Johnson K et al (2003) Obesity, tamoxifen use and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467–1476
Lamar CA, Dorgan JF, Longcope C et al (2003) Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol Biomarkers Prev 12:380–383
Cullen KJ, Yee D, Sly WS et al (1990) Insulin like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53
Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51
Rose DP, Komninou D, Stephenson GD (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5:153–165
Weiderpass E, Gridley G, Persson I et al (1997) Risk of endometrial and breast cancer in patient with diabetes mellitus. Int J Cancer Inst 71:360–363
Pasanisi P, Berrino F, De Petris M et al (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238
Rock CL, Demark-Wahnefried W (1997) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Am Diet Assoc 97:519–526
Parmenter K, Wardle J (1999) Development of general nutrition knowledge questionnaire for adults. Eur J Clin Nutr 53:298–308
Patella M, Bajardi M, Trento M et al (2003) Psychometric reliability of the Italian general nutrition knowledge questionnaire (Abstract). Ann Nutr Metab 47:517
Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Dixon J, Moritz D, Baker F (1978) Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum 5:5–7
Demark-Wahnefried W, Rimer BK, Winer EP (1997) Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 97:519–529
Demark-Wahnefried W, Peterson BL, Winer EP et al (2001) Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19:2381–2389
Goodwing PJ (2001) Weight gain in early-stage breast cancer: where do we go from here? J Clin Oncol 19:2367–2369
Irwin ML, Crumley D, McTiernan A et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma: The Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97:1746–1757
Rock CL, Flatt SW, Newman V et al (1999) Factors associated with weight gain in women after diagnosis of breast cancer: Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 99:1212–1221
Andrykowski MA, Curran SL, Lighner R (1999) Off-treatment fatigue in breast cancer survivors. A controlled comparison. J Behav Med 21:1–18
Broeckel JA, Jacobsen PB, Horton J et al (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689–1696
Mouridsen HT (2006) Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women. Curr Med Res Opin 22:1609–1621
Vooqd AC, Ververs JM, Vingerhoets AJ et al (2003) A lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 90:76–81
Rissanen A, Heliovaara M, Knekt P et al (1990) Risk of disability and mortality due to overweight in a Finnish population. BMJ 301:835–837
Camoriano JK, Loprinzi CL, Ingle JN et al (1990) Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8:1327–1334
Levine EG, Raczynski JM, Carpenter JT (1991) Weight gain with breast cancer adjuvant treatment. Cancer 67:1954–1959
McInnes JA, Knobf MT (2001) Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer. Oncol Nurs Forum 28:675–684
Demark-Wahnefried W, Peterson B, McBride C et al (2000) Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88:674–684
Loprinzi CL, Athmann LM, O’Fallon J et al (1996) Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology 53:228–232
Thomson CA, Rock CL, Giuliano AR et al (2005) Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet. Eur J Nutr 44:18–25
Hebert JR, Ebbeling CB, Olendzki BC et al (2001) Change in women’s diet and body mass following intensive intervention for early-stage breast cancer. J Am Diet Assoc 101:421–431
Dansinger ML, Gleason JA, Griffith JL et al (2005) Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 293:43–53
De Waard F, Ramlau R, Mulders Y et al (1993) A feasibility study on weight reduction in obese postmenopausal breast cancer patients. Eur J Cancer Prev 2:233–238
Goldstein DJ (1992) Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 16:397–415
Pasanisi F, Contaldo F, De Simone G, Mancini M (2001) Benefits of sustained moderate weight loss in obesity. Nutr Metab Cardiovasc Dis 11:401–406
National Heart Lung and Blood Institute, National Institutes of Health (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity adults — the evidence report. Obes Res 6:51S–209S
Chlebowski RT, Blackburn GL, Thomson CA et al (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst 98:1767–1776
Dalle Grave R, Calugi S, Molinari E et al; the QUOVADIS Study Group (2005) Weight loss expectations in obese patients and treatment attrition: an observational multicenter study. Obesity Res 13:1961–1969
— (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP ATP-III) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497
Sinagra D, Amato C, Scarpita AM et al (2002) Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci 6:55–59